25 XP   0   0   10

Cardiol Therapeutics Inc Class A
Buy, Hold or Sell?

Let's analyse Cardiol Therapeutics Inc Class A together

PenkeI guess you are interested in Cardiol Therapeutics Inc Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cardiol Therapeutics Inc Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cardiol Therapeutics Inc Class A

I send you an email if I find something interesting about Cardiol Therapeutics Inc Class A.

Quick analysis of Cardiol Therapeutics Inc Class A (30 sec.)










What can you expect buying and holding a share of Cardiol Therapeutics Inc Class A? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.58
Expected worth in 1 year
$-0.49
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-1.07
Return On Investment
-61.3%

For what price can you sell your share?

Current Price per Share
$1.75
Expected price per share
$1.35 - $2.17
How sure are you?
50%

1. Valuation of Cardiol Therapeutics Inc Class A (5 min.)




Live pricePrice per Share (EOD)

$1.75

Intrinsic Value Per Share

$-3.79 - $-4.16

Total Value Per Share

$-3.20 - $-3.58

2. Growth of Cardiol Therapeutics Inc Class A (5 min.)




Is Cardiol Therapeutics Inc Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$37.9m$55.3m-$17.4m-46.0%

How much money is Cardiol Therapeutics Inc Class A making?

Current yearPrevious yearGrowGrow %
Making money-$22.4m-$22.9m$513.9k2.3%
Net Profit Margin0.0%-40,170.4%--

How much money comes from the company's main activities?

3. Financial Health of Cardiol Therapeutics Inc Class A (5 min.)




What can you expect buying and holding a share of Cardiol Therapeutics Inc Class A? (5 min.)

Welcome investor! Cardiol Therapeutics Inc Class A's management wants to use your money to grow the business. In return you get a share of Cardiol Therapeutics Inc Class A.

What can you expect buying and holding a share of Cardiol Therapeutics Inc Class A?

First you should know what it really means to hold a share of Cardiol Therapeutics Inc Class A. And how you can make/lose money.

Speculation

The Price per Share of Cardiol Therapeutics Inc Class A is $1.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cardiol Therapeutics Inc Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cardiol Therapeutics Inc Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.58. Based on the TTM, the Book Value Change Per Share is $-0.27 per quarter. Based on the YOY, the Book Value Change Per Share is $0.70 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cardiol Therapeutics Inc Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.35-19.7%-0.35-19.7%-0.35-20.2%-0.25-14.4%-0.21-12.2%
Usd Book Value Change Per Share-0.27-15.3%-0.27-15.3%0.7040.1%0.116.3%0.105.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.27-15.3%-0.27-15.3%0.7040.1%0.116.3%0.105.5%
Usd Price Per Share0.51-0.51-1.85-1.62-1.35-
Price to Earnings Ratio-1.48--1.48--5.24--7.87--6.56-
Price-to-Total Gains Ratio-1.90--1.90-2.63--45.09--45.09-
Price to Book Ratio0.88-0.88-2.18-7.88-6.56-
Price-to-Total Gains Ratio-1.90--1.90-2.63--45.09--45.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.75
Number of shares571
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.270.11
Usd Total Gains Per Share-0.270.11
Gains per Quarter (571 shares)-153.1162.87
Gains per Year (571 shares)-612.45251.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-612-6220251241
20-1225-12340503492
30-1837-18460754743
40-2450-245801006994
50-3062-3070012571245
60-3675-3682015091496
70-4287-4294017601747
80-4900-4906020121998
90-5512-5518022632249
100-6124-6130025152500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.03.00.050.0%3.03.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.03.00.050.0%3.03.00.050.0%

Fundamentals of Cardiol Therapeutics Inc Class A

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Fundamental data was last updated by Penke on 2024-04-09 08:18:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cardiol Therapeutics Inc Class A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cardiol Therapeutics Inc Class A earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-40,170.4%+40,170.4%
TTM-5Y-13,275.6%+13,275.6%
5Y-13,275.6%10Y-11,063.0%-2,212.6%
1.1.2. Return on Assets

Shows how efficient Cardiol Therapeutics Inc Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • -49.9% Return on Assets means that Cardiol Therapeutics Inc Class A generated $-0.50 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is -49.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -49.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.9%TTM-49.9%0.0%
TTM-49.9%YOY-36.0%-13.9%
TTM-49.9%5Y-73.7%+23.8%
5Y-73.7%10Y-70.0%-3.7%
1.1.3. Return on Equity

Shows how efficient Cardiol Therapeutics Inc Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • -59.3% Return on Equity means Cardiol Therapeutics Inc Class A generated $-0.59 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is -59.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -59.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.3%TTM-59.3%0.0%
TTM-59.3%YOY-41.5%-17.8%
TTM-59.3%5Y-84.2%+24.9%
5Y-84.2%10Y-79.9%-4.3%

1.2. Operating Efficiency of Cardiol Therapeutics Inc Class A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cardiol Therapeutics Inc Class A is operating .

  • Measures how much profit Cardiol Therapeutics Inc Class A makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-57,736.3%+57,736.3%
TTM-5Y-16,780.0%+16,780.0%
5Y-16,780.0%10Y-13,983.3%-2,796.7%
1.2.2. Operating Ratio

Measures how efficient Cardiol Therapeutics Inc Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY491.919-491.919
TTM-5Y151.507-151.507
5Y151.50710Y126.256+25.251

1.3. Liquidity of Cardiol Therapeutics Inc Class A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.27 means the company has $6.27 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 6.266. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.266. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.266TTM6.2660.000
TTM6.266YOY7.535-1.268
TTM6.2665Y10.354-4.087
5Y10.35410Y10.972-0.618
1.3.2. Quick Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 6.12 means the company can pay off $6.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 6.121. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.121. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.121TTM6.1210.000
TTM6.121YOY7.295-1.174
TTM6.1215Y7.726-1.605
5Y7.72610Y8.757-1.031

1.4. Solvency of Cardiol Therapeutics Inc Class A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cardiol Therapeutics Inc Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cardiol Therapeutics Inc Class A to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.16 means that Cardiol Therapeutics Inc Class A assets are financed with 15.8% credit (debt) and the remaining percentage (100% - 15.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.158. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.158. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.158TTM0.1580.000
TTM0.158YOY0.132+0.026
TTM0.1585Y0.121+0.037
5Y0.12110Y0.120+0.001
1.4.2. Debt to Equity Ratio

Measures if Cardiol Therapeutics Inc Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 18.8% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cardiol Therapeutics Inc Class A:

  • The MRQ is 0.188. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.188. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.188TTM0.1880.000
TTM0.188YOY0.153+0.036
TTM0.1885Y0.141+0.048
5Y0.14110Y0.139+0.002

2. Market Valuation of Cardiol Therapeutics Inc Class A

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cardiol Therapeutics Inc Class A generates.

  • Above 15 is considered overpriced but always compare Cardiol Therapeutics Inc Class A to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.48 means the investor is paying $-1.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is -5.072. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.478. Based on the earnings, the company is expensive. -2
  • The TTM is -1.478. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.072MRQ-1.478-3.594
MRQ-1.478TTM-1.4780.000
TTM-1.478YOY-5.242+3.764
TTM-1.4785Y-7.870+6.392
5Y-7.87010Y-6.558-1.312
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is -5.747. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.675. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.675. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.747MRQ-1.675-4.072
MRQ-1.675TTM-1.6750.000
TTM-1.675YOY-7.038+5.363
TTM-1.6755Y-11.349+9.674
5Y-11.34910Y-9.457-1.891
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cardiol Therapeutics Inc Class A is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cardiol Therapeutics Inc Class A:

  • The EOD is 3.005. Based on the equity, the company is fair priced.
  • The MRQ is 0.876. Based on the equity, the company is cheap. +2
  • The TTM is 0.876. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.005MRQ0.876+2.129
MRQ0.876TTM0.8760.000
TTM0.876YOY2.175-1.299
TTM0.8765Y7.876-7.000
5Y7.87610Y6.563+1.313
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cardiol Therapeutics Inc Class A.

3.1. Institutions holding Cardiol Therapeutics Inc Class A

Institutions are holding 13.428% of the shares of Cardiol Therapeutics Inc Class A.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Mmcap International Inc. Spc4.53560.4863295330000
2023-12-31AdvisorShares Investments, LLC1.82750.2341189978-15810-1.3112
2023-12-31Tejara Capital Ltd1.7150.3944111667647121973.0055
2023-12-31AXS Investments LLC1.07140.1389697651-75884-9.81
2023-12-31Lion Street Advisors, LLC0.29590.06581927001927000
2023-12-31Bank of Montreal0.16050104479-6675-6.0052
2023-12-31BMO Capital Markets Corp.0.16050104479-6675-6.0052
2023-12-31Laird Norton Tyee Trust Co0.15360.0110000000
2023-12-31We Are One Seven, LLC0.15360.004810000000
2023-12-31CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.13080.00038520100
2023-12-31Credit Suisse First Boston (CSFB)0.12290.0001800003000060
2023-12-31Advisor Group Holdings, Inc.0.10260.000166800-2000-2.907
2023-12-31Geode Capital Management, LLC0.080505243500
2023-12-31Goldman Sachs Group Inc0.072204700023500100
2023-12-31Marble Harbor Investment Counsel, LLC0.05670.00383690000
2023-12-31Royal Bank of Canada0.0524034107-10342-23.2671
2023-12-31Two Sigma Advisers, LLC0.02601690000
2023-12-31Private Ocean, LLC0.02330.00131515100
2023-12-31Raymond James & Associates0.0171011154111540
2023-12-31TD Waterhouse Canada Inc0.01060.0001690000
Total 10.76871.33997011811+611187+8.7%

3.2. Funds holding Cardiol Therapeutics Inc Class A

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29AdvisorShares Pure Cannabis ETF1.98115.814128997800
2023-09-22Medical Cannabis and Wellness ETF Acc0.13180.919385850-42922-33.3318
2024-01-31Fidelity Nasdaq Composite Index0.08050.00045243500
2024-02-29Ninepoint Alternative Health A0.01920.14821250000
2023-12-31DFA Canadian Core Equity Class F0.01770.00041150000
Total 2.23036.88231452263-42922-3.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cardiol Therapeutics Inc Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.268-0.2680%0.702-138%0.110-344%0.097-376%
Book Value Per Share--0.5820.5820%0.850-32%0.399+46%0.337+73%
Current Ratio--6.2666.2660%7.535-17%10.354-39%10.972-43%
Debt To Asset Ratio--0.1580.1580%0.132+20%0.121+30%0.120+32%
Debt To Equity Ratio--0.1880.1880%0.153+23%0.141+34%0.139+36%
Dividend Per Share----0%-0%-0%-0%
Eps---0.345-0.3450%-0.353+2%-0.252-27%-0.213-38%
Free Cash Flow Per Share---0.304-0.3040%-0.263-14%-0.185-39%-0.156-49%
Free Cash Flow To Equity Per Share---0.305-0.3050%0.780-139%0.121-352%0.105-390%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---4.159--------
Intrinsic Value_10Y_min---3.787--------
Intrinsic Value_1Y_max---0.235--------
Intrinsic Value_1Y_min---0.265--------
Intrinsic Value_3Y_max---0.845--------
Intrinsic Value_3Y_min---0.901--------
Intrinsic Value_5Y_max---1.622--------
Intrinsic Value_5Y_min---1.645--------
Market Cap113949325.000+71%33208089.00033208089.0000%120460715.000-72%105171971.280-68%87643309.400-62%
Net Profit Margin----0%-401.7040%-132.7560%-110.6300%
Operating Margin----0%-577.3630%-167.8000%-139.8330%
Operating Ratio----0%491.919-100%151.507-100%126.256-100%
Pb Ratio3.005+71%0.8760.8760%2.175-60%7.876-89%6.563-87%
Pe Ratio-5.072-243%-1.478-1.4780%-5.242+255%-7.870+432%-6.558+344%
Price Per Share1.750+71%0.5100.5100%1.850-72%1.615-68%1.346-62%
Price To Free Cash Flow Ratio-5.747-243%-1.675-1.6750%-7.038+320%-11.349+578%-9.457+465%
Price To Total Gains Ratio-6.526-243%-1.902-1.9020%2.634-172%-45.094+2271%-45.094+2271%
Quick Ratio--6.1216.1210%7.295-16%7.726-21%8.757-30%
Return On Assets---0.499-0.4990%-0.360-28%-0.737+48%-0.700+40%
Return On Equity---0.593-0.5930%-0.415-30%-0.842+42%-0.799+35%
Total Gains Per Share---0.268-0.2680%0.702-138%0.110-344%0.097-376%
Usd Book Value--37919233.52337919233.5230%55379337.680-32%25955174.479+46%21974827.374+73%
Usd Book Value Change Per Share---0.268-0.2680%0.702-138%0.110-344%0.097-376%
Usd Book Value Per Share--0.5820.5820%0.850-32%0.399+46%0.337+73%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.345-0.3450%-0.353+2%-0.252-27%-0.213-38%
Usd Free Cash Flow---19827127.226-19827127.2260%-17116668.048-14%-12028742.639-39%-10183925.455-49%
Usd Free Cash Flow Per Share---0.304-0.3040%-0.263-14%-0.185-39%-0.156-49%
Usd Free Cash Flow To Equity Per Share---0.305-0.3050%0.780-139%0.121-352%0.105-390%
Usd Market Cap113949325.000+71%33208089.00033208089.0000%120460715.000-72%105171971.280-68%87643309.400-62%
Usd Price Per Share1.750+71%0.5100.5100%1.850-72%1.615-68%1.346-62%
Usd Profit---22468021.981-22468021.9810%-22982020.442+2%-16385780.204-27%-13855899.611-38%
Usd Revenue----0%57211.264-100%22884.506-100%19070.421-100%
Usd Total Gains Per Share---0.268-0.2680%0.702-138%0.110-344%0.097-376%
 EOD+5 -3MRQTTM+0 -0YOY+6 -255Y+9 -2210Y+9 -22

4.2. Fundamental Score

Let's check the fundamental score of Cardiol Therapeutics Inc Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.072
Price to Book Ratio (EOD)Between0-13.005
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.121
Current Ratio (MRQ)Greater than16.266
Debt to Asset Ratio (MRQ)Less than10.158
Debt to Equity Ratio (MRQ)Less than10.188
Return on Equity (MRQ)Greater than0.15-0.593
Return on Assets (MRQ)Greater than0.05-0.499
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Cardiol Therapeutics Inc Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.474
Ma 20Greater thanMa 501.786
Ma 50Greater thanMa 1001.608
Ma 100Greater thanMa 2001.296
OpenGreater thanClose1.710
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets62,029
Total Liabilities9,827
Total Stockholder Equity52,202
 As reported
Total Liabilities 9,827
Total Stockholder Equity+ 52,202
Total Assets = 62,029

Assets

Total Assets62,029
Total Current Assets61,438
Long-term Assets591
Total Current Assets
Cash And Cash Equivalents 59,470
Short-term Investments 62
Net Receivables 480
Other Current Assets 1,488
Total Current Assets  (as reported)61,438
Total Current Assets  (calculated)61,500
+/- 62
Long-term Assets
Property Plant Equipment 296
Intangible Assets 295
Long-term Assets  (as reported)591
Long-term Assets  (calculated)591
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,805
Long-term Liabilities22
Total Stockholder Equity52,202
Total Current Liabilities
Short-term Debt 50
Accounts payable 8,349
Other Current Liabilities 9,754
Total Current Liabilities  (as reported)9,805
Total Current Liabilities  (calculated)18,154
+/- 8,349
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt22
Long-term Liabilities  (as reported)22
Long-term Liabilities  (calculated)22
+/-0
Total Stockholder Equity
Common Stock147,545
Retained Earnings -114,449
Accumulated Other Comprehensive Income 3,518
Other Stockholders Equity 15,587
Total Stockholder Equity (as reported)52,202
Total Stockholder Equity (calculated)52,202
+/-0
Other
Capital Stock147,545
Cash and Short Term Investments 59,470
Common Stock Shares Outstanding 62,506
Current Deferred Revenue-8,349
Liabilities and Stockholders Equity 62,029
Net Debt -59,397
Net Invested Capital 52,202
Net Tangible Assets 51,907
Net Working Capital 51,633
Property Plant and Equipment Gross 789
Short Long Term Debt Total 73



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
3,221
24,685
15,503
15,893
87,876
62,029
62,02987,87615,89315,50324,6853,221
   > Total Current Assets 
2,485
24,027
14,371
14,950
87,140
61,438
61,43887,14014,95014,37124,0272,485
       Cash And Cash Equivalents 
2,357
16,732
6,956
14,025
83,899
59,470
59,47083,89914,0256,95616,7322,357
       Short-term Investments 
0
0
61
62
62
62
6262626100
       Net Receivables 
102
461
928
220
407
480
480407220928461102
       Other Current Assets 
0
489
5,368
687
2,834
1,488
1,4882,8346875,3684890
   > Long-term Assets 
736
658
1,132
943
736
591
5917369431,132658736
       Property Plant Equipment 
19
26
584
480
356
296
2963564805842619
       Intangible Assets 
717
633
548
464
379
295
295379464548633717
> Total Liabilities 
367
2,411
831
2,623
11,638
9,827
9,82711,6382,6238312,411367
   > Total Current Liabilities 
177
2,141
691
2,518
11,565
9,805
9,80511,5652,5186912,141177
       Short-term Debt 
0
0
50
52
45
50
5045525000
       Accounts payable 
177
2,141
561
1,770
4,188
8,349
8,3494,1881,7705612,141177
       Other Current Liabilities 
11
10
640
2,466
11,520
9,754
9,75411,5202,4666401011
   > Long-term Liabilities 
190
269
140
105
73
22
2273105140269190
       Long term Debt 
190
269
0
0
0
0
0000269190
       Capital Lease Obligations Min Short Term Debt
0
0
140
105
73
22
227310514000
> Total Stockholder Equity
2,854
22,274
14,672
13,270
76,238
52,202
52,20276,23813,27014,67222,2742,854
   Common Stock
4,255
36,722
39,414
51,923
142,919
147,545
147,545142,91951,92339,41436,7224,255
   Retained Earnings -114,449-83,518-51,880-31,239-17,555-1,661
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
259
3,106
4,766
8,766
12,660
15,587
15,58712,6608,7664,7663,106259



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-30,852
Operating Income-30,852-30,852
 
Operating Expense (+$)
Research Development15,802
Selling General Administrative15,050
Selling And Marketing Expenses-
Operating Expense30,85230,852
 
Net Interest Income (+$)
Interest Income2,175
Interest Expense--
Other Finance Cost-0
Net Interest Income2,175
 
Pretax Income (+$)
Operating Income-30,852
Net Interest Income2,175
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-28,006-31,522
EBIT - interestExpense = 0
-28,006
-28,006
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--28,006
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-28,006
Tax Provision--
Net Income From Continuing Ops-28,006-28,006
Net Income-28,006
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net671-2,175
 

Technical Analysis of Cardiol Therapeutics Inc Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cardiol Therapeutics Inc Class A. The general trend of Cardiol Therapeutics Inc Class A is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cardiol Therapeutics Inc Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cardiol Therapeutics Inc Class A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.07 < 2.17.

The bearish price targets are: 1.43 > 1.43 > 1.35.

Tweet this
Cardiol Therapeutics Inc Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cardiol Therapeutics Inc Class A. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cardiol Therapeutics Inc Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cardiol Therapeutics Inc Class A. The current macd is 0.06527428.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cardiol Therapeutics Inc Class A price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cardiol Therapeutics Inc Class A. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cardiol Therapeutics Inc Class A price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cardiol Therapeutics Inc Class A Daily Moving Average Convergence/Divergence (MACD) ChartCardiol Therapeutics Inc Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cardiol Therapeutics Inc Class A. The current adx is 34.92.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cardiol Therapeutics Inc Class A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Cardiol Therapeutics Inc Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cardiol Therapeutics Inc Class A. The current sar is 2.0626.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cardiol Therapeutics Inc Class A Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cardiol Therapeutics Inc Class A. The current rsi is 50.47. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Cardiol Therapeutics Inc Class A Daily Relative Strength Index (RSI) ChartCardiol Therapeutics Inc Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cardiol Therapeutics Inc Class A. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cardiol Therapeutics Inc Class A price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cardiol Therapeutics Inc Class A Daily Stochastic Oscillator ChartCardiol Therapeutics Inc Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cardiol Therapeutics Inc Class A. The current cci is -13.62679874.

Cardiol Therapeutics Inc Class A Daily Commodity Channel Index (CCI) ChartCardiol Therapeutics Inc Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cardiol Therapeutics Inc Class A. The current cmo is -7.16081677.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cardiol Therapeutics Inc Class A Daily Chande Momentum Oscillator (CMO) ChartCardiol Therapeutics Inc Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cardiol Therapeutics Inc Class A. The current willr is -86.48648649.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cardiol Therapeutics Inc Class A Daily Williams %R ChartCardiol Therapeutics Inc Class A Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cardiol Therapeutics Inc Class A.

Cardiol Therapeutics Inc Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cardiol Therapeutics Inc Class A. The current atr is 0.15662005.

Cardiol Therapeutics Inc Class A Daily Average True Range (ATR) ChartCardiol Therapeutics Inc Class A Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cardiol Therapeutics Inc Class A. The current obv is 2,845,467.

Cardiol Therapeutics Inc Class A Daily On-Balance Volume (OBV) ChartCardiol Therapeutics Inc Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cardiol Therapeutics Inc Class A. The current mfi is 52.70.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cardiol Therapeutics Inc Class A Daily Money Flow Index (MFI) ChartCardiol Therapeutics Inc Class A Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cardiol Therapeutics Inc Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Cardiol Therapeutics Inc Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cardiol Therapeutics Inc Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.474
Ma 20Greater thanMa 501.786
Ma 50Greater thanMa 1001.608
Ma 100Greater thanMa 2001.296
OpenGreater thanClose1.710
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cardiol Therapeutics Inc Class A with someone you think should read this too:
  • Are you bullish or bearish on Cardiol Therapeutics Inc Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cardiol Therapeutics Inc Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cardiol Therapeutics Inc Class A

I send you an email if I find something interesting about Cardiol Therapeutics Inc Class A.


Comments

How you think about this?

Leave a comment

Stay informed about Cardiol Therapeutics Inc Class A.

Receive notifications about Cardiol Therapeutics Inc Class A in your mailbox!